Morgan Stanley analyst Jefferson Harralson reinstates Exelixis (NASDAQ:EXEL) with a Equal-Weight and announces $21 price target.
Morgan Stanley analyst Jefferson Harralson reinstates Exelixis (NASDAQ:EXEL) with a Equal-Weight and announces $21 price target.